Tech Company Financing Transactions
MolecularMD Funding Round
MolecularMD, operating out of Portland, raised $6 million from Ballast Point Ventures and Nextech Invest.
Transaction Overview
Company Name
Announced On
4/2/2012
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Investors
Ballast Point Ventures (Lead Investor) (Dick Brandewie)
Proceeds Purpose
Proceeds from the Series B investment will accelerate the commercial launch of new platforms and related assay content in such areas such as next generation sequencing and rare mutant detection. Investment proceeds will also be applied to the expansion of sales and marketing activities to support near term growth objectives.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1341 SW. Custer Dr.
Portland, OR 97219
USA
Portland, OR 97219
USA
Phone
Website
Email Address
Overview
Founded in 2006, MolecularMD is a molecular diagnostics company specializing in clinical development and commercialization of state-of-the-art genomic assays to measure patient response and resistance to targeted cancer therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Snyder
Chief Financial Officer
Ryan Dunlap
Chief Marketing Officer
Fritz Eibel
Chief Medical Officer
Chad Galderisi
VP - Regulatory Affairs
Cindy Spittle
Browse more venture capital transactions:
Prev: 4/2/2012: AlloCure venture capital transaction
Next: 4/2/2012: FireScope venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs